N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide

C27H33N7O7S2 — CID 138810239

IUPACN-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide
SMILESCC(C)[C@@H]1NC(=O)CN(C(=O)CNS(C)(=O)=O)CCNC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)c2csc1n2
InChIInChI=1S/C27H33N7O7S2/c1-16(2)23-27-32-20(15-42-27)25(38)30-18(11-17-7-5-4-6-8-17)26-31-19(14-41-26)24(37)28-9-10-34(13-21(35)33-23)22(36)12-29-43(3,39)40/h4-8,14-16,18,23,29H,9-13H2,1-3H3,(H,28,37)(H,30,38)(H,33,35)/t18-,23-/m0/s1
InChIKeyNLXGNPRUWVOXSE-MBSDFSHPSA-N
MW631.74 g/mol
LogP0.78
Rot. Bonds6

About N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide

N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide (PubChem CID 138810239) has the molecular formula C27H33N7O7S2 and a molecular weight of 631.74 g/mol. Its IUPAC name is N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide.

Molecular Properties

Compound NameN-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide
PubChem CID138810239
Molecular FormulaC27H33N7O7S2
Molecular Weight631.74 g/mol
Exact Mass631.19
IUPAC NameN-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide
SMILESCC(C)[C@@H]1NC(=O)CN(C(=O)CNS(C)(=O)=O)CCNC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)c2csc1n2
InChIInChI=1S/C27H33N7O7S2/c1-16(2)23-27-32-20(15-42-27)25(38)30-18(11-17-7-5-4-6-8-17)26-31-19(14-41-26)24(37)28-9-10-34(13-21(35)33-23)22(36)12-29-43(3,39)40/h4-8,14-16,18,23,29H,9-13H2,1-3H3,(H,28,37)(H,30,38)(H,33,35)/t18-,23-/m0/s1
InChIKeyNLXGNPRUWVOXSE-MBSDFSHPSA-N
XLogP0.78
TPSA192.70 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds6
Heavy Atoms43
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500631.74
LogP ≤ 50.78
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Analyze N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide?
The IUPAC name of N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide (CID 138810239) is N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide.
What is the SMILES notation for N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide?
The canonical SMILES for N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide is CC(C)[C@@H]1NC(=O)CN(C(=O)CNS(C)(=O)=O)CCNC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)c2csc1n2.
What is the InChIKey of N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide?
The InChIKey is NLXGNPRUWVOXSE-MBSDFSHPSA-N. The full InChI is InChI=1S/C27H33N7O7S2/c1-16(2)23-27-32-20(15-42-27)25(38)30-18(11-17-7-5-4-6-8-17)26-31-19(14-41-26)24(37)28-9-10-34(13-21(35)33-23)22(36)12-29-43(3,39)40/h4-8,14-16,18,23,29H,9-13H2,1-3H3,(H,28,37)(H,30,38)(H,33,35)/t18-,23-/m0/s1.
What are the key properties of N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide?
N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide has a molecular weight of 631.74 g/mol, XLogP of 0.78, 6 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(4S,17S)-4-benzyl-2,9,15-trioxo-17-propan-2-yl-6-oxa-19-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraen-13-yl]-2-oxoethyl]methanesulfonamide is sourced from PubChem (CID 138810239), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).